Found: 22
Select item for more details and to access through your institution.
The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures.
- Published in:
- Contrast Media & Molecular Imaging, 2008, v. 3, n. 5, p. 191, doi. 10.1002/cmmi.251
- By:
- Publication type:
- Article
Comparing ARIA‐E severity scales and effects of treatment management thresholds.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.063848
- By:
- Publication type:
- Article
Considerations for the real‐world management of ARIA from the aducanumab phase 3 studies EMERGE and ENGAGE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057498
- By:
- Publication type:
- Article
Calibration of a simplified ARIA‐E MRI severity scale suitable for clinical practice: Human neuropathology/imaging‐pathologic correlations.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041110
- By:
- Publication type:
- Article
Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities.
- Published in:
- 2017
- By:
- Publication type:
- journal article
VALIDATION OF A SIMPLE SEVERITY SCALE FOR ASSESSING ARIA-E.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P34, doi. 10.1016/j.jalz.2017.06.2311
- By:
- Publication type:
- Article
USING SUBTRACTION MRI TO IMPROVE THE DETECTION OF AMYLOID-RELATED IMAGING ABNORMALITIES WITH EDEMA OR EFFUSION (ARIA-E) IN PATIENTS AFFECTED BY ALZHEIMER’S DISEASE RECEIVING IMMUNOTHERAPY: AN INTER-OBSERVER STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P425, doi. 10.1016/j.jalz.2017.06.416
- By:
- Publication type:
- Article
VALIDATION OF A SIMPLE SEVERITY SCALE FOR ASSESSING ARIA-E.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P253, doi. 10.1016/j.jalz.2017.06.114
- By:
- Publication type:
- Article
Two temporal bone computed tomography measurements increase recognition of malformations and predict sensorineural hearing loss.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Two Temporal Bone Computed Tomography Measurements Increase Recognition of Malformations and Predict Sensorineural Hearing Loss.
- Published in:
- Laryngoscope, 2006, v. 116, n. 8, p. 1439, doi. 10.1097/01.mlg.0000229826.96593.13
- By:
- Publication type:
- Article
Identification of Previously Undetectable Abnormalities of the Bony Labyrinth with Computed Tomography Measurement.
- Published in:
- Laryngoscope, 2003, v. 113, n. 11, p. 1908
- By:
- Publication type:
- Article
Identification of previously "undetectable" abnormalities of the bony labyrinth with computed tomography measurement.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Intracranial time-of-flight MR angiography at 7T with comparison to 3T.
- Published in:
- Journal of Magnetic Resonance Imaging, 2007, v. 26, n. 4, p. 900, doi. 10.1002/jmri.21097
- By:
- Publication type:
- Article
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 1, p. 13, doi. 10.1001/jamaneurol.2021.4161
- By:
- Publication type:
- Article
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK‐6240 tau PET.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12372
- By:
- Publication type:
- Article
Validation of 3‐ and 5‐point severity scales to assess ARIA‐E.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 4, p. 1, doi. 10.1002/dad2.12503
- By:
- Publication type:
- Article
Comparing ARIA‐E severity scales and effects of treatment management thresholds.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12376
- By:
- Publication type:
- Article
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
Establishment of normative cochlear and vestibular measurements to aid in the diagnosis of inner ear malformations
- Published in:
- 2003
- By:
- Publication type:
- journal article